Allergy

Allergies are incurable, but OTC products can help patients function.

Here are new drugs for 2015 pharmacists can expect to handle.

Alpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.

Elite Pharmaceuticals has launched a generic version of Atarax and Vistaril in 3 tablet strengths.

Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, details some lesser known facts about some allergic rhinitis treatments.

A study investigating allergic reactions in mice has indicated that estrogen plays a role in triggering anaphylaxis, providing a potential clue as to why women experience severe allergic reactions more frequently than men.

Sufferers of spring allergies may be able to reduce their seasonal flareups by lowering their stress level, according to a study.

Introducing peanut products into the diets of infants can reduce their risk of developing a peanut allergy, a study suggests.

Phenylephrine hydrochloride is a recognized contact allergen with symptoms remarkably similar to those of a cold.

CCZ impairs the ability of the virus to enter human liver cells.

Efforts are being made to ensure that health care providers deliver the right care at the right time.

Many children with food allergies develop micronutrient deficiencies.

An OTC allergy medication may be able to kill the bacteria behind Lyme disease, bringing researchers closer to developing the first targeted therapy for the debilitating infection.

Wockhardt USA LLC introduces its newest private label, OTC medication Fexofenadine in a small, easy-to-swallow tablet for next year's fall allergy season.

The majority of patients who require inhalers for asthma or epinephrine autoinjectors for allergic disease for do not use the devices properly.

Many patients who claim to have penicillin allergies may not actually be allergic to the antibiotic.

Mylan Inc. today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® and EpiPen Jr® Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.

Pharmacists generally demonstrate proper epinephrine auto injector use to anaphylaxis patients.

While food allergies can spark fearful thoughts and concerns, they can be quite manageable with awareness and modifications.

Is there such a phenomenon as corticosteroid-induced anaphylaxis?

Researchers found that inhibiting development of T helper 2 cells may be advantageous in the control of allergic responses.

Allergy prevalence among Americans older than 5 years is the same across different regions of the country, the results of a recent study indicate.